Literature DB >> 9342954

Evaluation of four Narcissus cultivars as potential sources for galanthamine production.

R M Moraes-Cerdeira, C L Burandt, J K Bastos, D Nanayakkara, J Mikell, J Thurn, J D McChesney.   

Abstract

Galanthamine, an alkaloid present in the Amaryllidaceae is currently undergoing clinical trials for the treatment of Alzheimer's. Common daffodils, Narcissus spp., contain galanthamine and other alkaloids. Four commercial Narcissus cultivars were evaluated as potential sources of galanthamine. Planting depths, planting densities, bulb size or flower bud removal did not affect galanthamine content.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9342954     DOI： 10.1055/s-2006-957740

Source DB:  PubMed          Journal:  Planta Med        ISSN： 0032-0943            Impact factor:   3.352


  5 in total

1.  Efficient callus induction and plant regeneration from anther of Chinese narcissus (Narcissus tazetta L. var. chinensis Roem).

Authors:  LinJiao Chen; XueYi Zhu; Li Gu; Jian Wu
Journal:  Plant Cell Rep       Date:  2005-04-21       Impact factor: 4.570

Review 2.  Chemical and biological aspects of Narcissus alkaloids.

Authors:  Jaume Bastida; Rodolfo Lavilla; Francesc Viladomat
Journal:  Alkaloids Chem Biol       Date:  2006

Review 3.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  New Gold in Them Thar Hills: Testing a Novel Supply Route for Plant-Derived Galanthamine.

Authors:  Mariecia D Fraser; John R T Davies; Xianmin Chang
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.

Authors:  Swarup Mitra; Shailesh N Khatri; Malabika Maulik; Abel Bult-Ito; Marvin Schulte
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.